Justin Chakma, Chief Business Officer: ARS Pharmaceuticals SPRY Sell · Filed 24/12/13

Trade details

Type: Insider sale
Amount: $328,900.32
Shares · price: 27,272 sh · $12.06 a share
Held after: 136,380 sh
Stock: ARS Pharmaceuticals SPRY
Person: Justin ChakmaChief Business Officer
Trade date: 24/12/13
Filed: 24/12/13
Days to filing: 0 days

Sold 16.7% of holdings

Share of holding sold: 16.7%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/11/13~25/01/12

Justin Chakma's recent trades

Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$1.2M
136,380 sh
$1.2M
Filed 25/11/14
Traded 25/11/12
Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$267.3K
30,000 sh
$267.3K
Filed 25/11/14
Traded 25/11/12
Justin ChakmaChief Business Officer
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$267.4K
30,000 sh
$267.4K
Filed 25/11/12
Traded 25/11/12
Justin ChakmaChief Business Officer
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$1.2M
138,380 sh
$1.2M
Filed 25/11/12
Traded 25/11/12
Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$1.4M
117,333 sh
$1.4M
Filed 24/12/13
Traded 24/12/12

Justin Chakma, Chief Officer — sold $328.9K of ARS Pharmaceuticals SPRY · 16.7% of holdings | Whalegun